mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.8 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |